Veterans Affairs' health, benefits app passes 3 million downloads
June 6 (UPI) -- The Department of Veterans Affairs' Health and Benefits mobile app has achieved more than 3 million downloads, or nearly 20% of all veterans, since its launch in 2021.
The app has 1.4 million active users, according to an agency news release Friday on the 81st anniversary of D-Day, which was the Allies' amphibious invasion of German-occupied France.
The app provides veterans access to healthcare and benefits information from their mobile phones, and features fingerprint and face recognition. Users can refill and track VA prescriptions, review appointments, review claims and appeals status, submit evidence for claims and appeals, review VA payment and direct deposit information, locate the closest VA facilities, access the Veterans Crisis Line and show proof of veteran status.
"We encourage all VA-enrolled Veterans to stay connected and informed by downloading the app," Eddie Pool, acting assistant Secretary for Information and Technology and acting chief information officer, said in a news release.
In all, there are 15.8 million veterans, which represents 6.1% of the civilian population 18 year and older. Of those, 7.8 million served in the Gulf War era between 1990 and now, 5.6 million during the Vietnam era from 1950 to 1073, 767,000 during the Korean conflict in the 1940s and 1950s, and less than 120,000 World War II veterans, according to Pew Research in 2023.
As of 2023, 78% of veterans served during wartime.
The Department of Veterans Affairs employs approximately 482,000 people, including 500,000 workers at 170 hospitals and 1,200 local clinics in the nation's largest health care system.
Like with other agencies, the agency is being downsized with plans to cut 83,000 jobs.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
UPI
2 hours ago
- UPI
More than 700 HHS staffers tell Kennedy to end fake info spreading
1 of 2 | U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. testified in May at a Senate Committee on Health, Education, Labor and Pensions hearing in the Dirksen Senate office building in Washington, DC. Over 700 HHS currenty and former HHS workers are calling on Kennedy to stop spreading false health statistics and protect public health sector professionals. File Photo by Annabelle Gordon/UPI | License Photo Aug. 20 (UPI) -- Hundreds of staff from the U.S. Department of Health and Human Services told Congress that HHS Secretary Robert F. Kennedy Jr. is sharing false health info with the public and called on him to step up protection of public health professionals. They accused Kennedy of complicity in "dismantling America's public health infrastructure and endangering the nation's health." More than 750 current and former HHS employees on Wednesday called on Kennedy to stop "spreading inaccurate health information" and prioritize the safety of public servants in the health sector in the wake of this month's fatal shooting at the Atlanta headquarters of the U.S. Centers for Disease Control and Prevention. "The attack came amid growing mistrust in public institutions, driven by politicized rhetoric that has turned public health professionals from trusted experts into targets of villainization," the letter to members of Congress read in part. "And now, violence," it added. The "Save HHS" crew accused Kennedy, 71, of endangering the lives of his HHS employees with his own words and rhetoric, and pointed to multiple specific accusations in the letter of Kennedy doing so in the public square. According to law enforcement, the alleged shooter was skeptical of the COVID-19 vaccine and assumed he was harmed by it. He fired hundreds of rounds with about 200 striking six different CDC facilities across its Atlanta campus. CDC Director Susan Monarez told HHS staffers during a 10,000-person virtual call the danger of misinformation had "now led to deadly consequences." Kennedy met with Monarez two days after the shooting. The HHS crew noted the recent CDC attack on Aug. 8, where DeKalb County police officer David Rose was fatally shot was "not random." "If the very people that are supposed to be protecting Americans are not safe, then no American is safe," Dr. Anne Schuchat, former principal deputy director of the CDC, said in a statement. The letter also noted the HHS workforce wanted to honor Rose and his memory. But it also pointed to fears of "retaliation" and issues of "personal safety." "We sign this declaration in our own personal capacities, on our personal time, and without the use of government equipment, as protected by our First Amendment rights," they stated. Health experts and other officials have rung alarm bells over Kennedy's deployment of health data universally known as false for years, even before U.S. President Donald Trump nominated Kennedy to be the nation's health chief. Wednesday's letter follows a similar letter to Congress in January signed by more than 17,000 U.S. doctors via the Chicago-based Committee to Protect Health Care, which stated Kennedy was a danger to America's national healthcare system.
Forbes
5 hours ago
- Forbes
Trump's First Term Degraded Military Health. His Second Must Rebuild It
Recently, Senators McConnell (R-KY) and Coons (D-DE) cosponsored a bill to invest more than $850 billion to strengthen our nation's defense industrial base, upgrade its shipbuilding capabilities, replenish munitions, and support key allies. Although these are worthy goals, Congress and the White House must not overlook the system that safeguards the health of American warfighters - our military's most important asset. Last March, the Chair of the Senate Armed Services Committee, Senator Roger Wicker (R-MS), made pointed remarks at the outset of a hearing on stabilizing the military health system: America's Military Health System Is Unique Unlike the Veterans Health Administration (VHA) or private healthcare systems, military health must always be ready to deploy uniformed healthcare professionals anywhere in the world in support 0f U.S. combat operations and other missions, including peacekeeping and humanitarian assistance. To enable this work, the MHS maintains a network of stateside military hospitals and clinics, supplemented by healthcare purchased from private doctors and healthcare systems to treat active-duty service members, their family members, and military retirees. This second mission reinforces the first. The clinical duties that military doctors, nurses, and other health professionals perform in stateside military hospitals helps keep their skills sharp between deployments. It also allows them to teach and inspire the next generation of military healthcare professionals. In times of conflict, military hospitals receive and treat complex casualties. Finally, the high-quality care to wounded, ill and injured servicemembers as well as their families and military retirees helps the DoD recruit and retain its 'all-volunteer' force. Healthy Forces Are Vital For Battlefield Success Military health has played a key role in American history since the founding of our republic. In the Winter of 1777, General George Washington ordered the inoculation of the Continental Army against smallpox. It was the first time in history that an Army was immunized by command order. Washington also instituted policies on camp cleanliness and took other actions to preserve his army's fighting strength. The principles he established still guide military medicine to this day. Health protection is so important to preserving fighting strength that the U.S. military monitors every unit's 'disease and non-battle injury (DNBI)' rates to evaluate the quality of its leadership and medical support. This discipline paid off in Afghanistan and Iraq. Despite logistical challenges and austere conditions, military medicine drove rates of DNBIs and deaths from severe battlefield wounds to the lowest levels in the history of warfare. It's one of the most remarkable achievements in the history of American medicine. Many of the innovations they pioneered have been adopted by civilian healthcare. Post-War Decisions Eroded Hard-Won Gains Instead of recognizing the value of military health, budget officials in the Pentagon viewed the MHS as little more than an HMO for beneficiaries. As the wars wound down, they began siphoning military health funding and positions for other DoD priorities. As a result, spending on military healthcare flattened, and is now far behind healthcare spending in the VA and our nation overall. During Trump's first term, the Pentagon compounded this error by directing military families and retirees to go elsewhere for treatment. Then, as visits and hospital admissions fell, they downsized or closed many military clinics and hospitals. Even top hospitals, such as Walter Reed and Naval Medical Center San Diego, were left underfunded, understaffed, and underutilized. This weakened the link between stateside care and battlefield care. By the time the Joint Chiefs of Staff realized that privatization had gone too far, the damage was done. In 2023, then Deputy Secretary of Defense Kathleen Hicks issued a directive to reverse course and begin restoring the MHS. What About Now? Today, different leaders are in charge. In the past, Defense Secretary Pete Hegseth has advocated diverting military and veteran healthcare benefits to enhance the Pentagon's "war-fighting capability." Military and veterans' healthcare IS a warfighting capability. It's a major reason why American servicemembers fight so hard, accept such risks and reenlist to do it again. Until recently, they knew that every time they were deployed, their families would be cared for by doctors and nurses who understood the stresses of military life. They were also confident that if anyone in their unit became ill or was wounded in battle, they'd receive the best healthcare in the world, expert rehabilitation, and if needed, long-term care. If the Pentagon resumes its push to privatize the military health system, it will harm the health of our armed forces and diminish their battlefield performance. Two former Hegseth aides said as much in a recent New York Times op-ed: Why You and Trump Should Care About Military Health Although most Americans give little thought to military health, servicemembers, veterans and military retirees know better. If any member of your family, a friend, or a neighbor currently serves in uniform, you should care. If one or more of your children or grandchildren are considering military service, you should care. If you value any of the numerous advances military health has contributed to American medicine throughout our nation's history, you should care. As Commander-in-Chief of our nation's armed forces, President Trump should care, and direct Defense Secretary Hegseth and his senior staff to rebuild our nation's military health system.
Yahoo
10 hours ago
- Yahoo
Lab Equipment Market and Supply Chain Forecasts 2025-2030 Featuring Eppendorf, Beckman Coulter, Agilent Technologies, Thermo Fisher Scientific, Waters Corp. & More
The Lab Equipment Market is projected to grow at 7% CAGR, driven by increased pharmaceutical R&D, rising chronic disease prevalence, and growing demand for biologics Lab Equipment Market Dublin, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The "Lab Equipment Market - Forecasts from 2025 to 2030" has been added to offering. The global lab equipment market foresees significant expansion, projected to grow from USD 19.507 billion in 2025 to USD 27.310 billion by 2030, registering a CAGR of 6.96%. This growth trajectory is underpinned by dynamic factors, anticipated to propel the market. Pharmaceutical R&D investments are a primary catalyst, with global spending reaching USD 280 billion in 2024, focusing on groundbreaking drugs and biologics. Streamlined clinical trial processes, exemplified by the European Medicines Agency's fast-track schemes reducing approval times, emphasize the demand for cutting-edge lab equipment essential for drug discovery. Chronic disease prevalence, including cancer, diabetes, and cardiovascular conditions, further accelerates market demand. In 2024, the U.S. recorded 1.9 million new cancer cases, underlining the urgency for advanced diagnostics and drug development. The rising chronic disease burden globally, particularly in aging populations, intensifies the need for sophisticated lab tools. Biologics, derived from living organisms, represent a rapidly growing market segment, accounting for a substantial portion of the pharmaceutical pipeline in 2024. With 40% of clinical trials targeting biologics, specialized lab equipment becomes indispensable for development and testing, driving market expansion. Segment-wise, the sensing equipment category, including spectrometers and conductivity meters, dominates due to its pivotal role in precise diagnostics and drug development. Biopharmaceutical companies hold the largest market share, bolstered by substantial R&D budgets and specialized equipment requirements. Government and academic institutions also contribute significantly, with increased public funding for health research. Geographically, North America leads with over 35% of global lab equipment revenue, supported by advanced healthcare infrastructure. Meanwhile, Asia-Pacific emerges as the fastest-growing region, buoyed by a rising incidence of chronic diseases and increased pharmaceutical investments. Europe's growth is reinforced by regulatory backing for innovative therapies. Key industry players, including Eppendorf AG and Thermo Fisher Scientific Inc., dominate due to robust brand reputations and innovative product offerings. For instance, in 2023, Thermo Fisher launched advanced spectrometry equipment for biologics research, enhancing precision and driving market leadership. Nevertheless, the market faces challenges such as high costs of advanced equipment and the requisite skilled personnel for operating complex systems. Regulatory requirements often delay market entry, necessitating continuous innovation to meet compliance standards. This report provides: Market insights spanning major and emerging regions, focusing on consumer tendencies and industry verticals. Understanding of strategies employed by global key players. Exploration of market drivers and future trends. Actionable insights for strategic business decisions. Catering to startups, research institutions, SMEs, and large enterprises. Report Highlights: Historical data (2022-2024) and forecast (2025-2030). Analysis of growth opportunities, challenges, and regional trends. Strategies and market share analysis of leading companies. Revenue growth projections by segments and regions. Company profiling, strategic developments, and product information. Lab Equipment Market Segmentation: By Type: Analytical Instruments, General Lab Equipment, Measuring & Monitoring Devices, Specialty Equipment, Support Equipment. By End-User: Academic & Research Institutes, Biopharmaceutical & Pharmaceutical Companies, Healthcare & Diagnostic Labs, Government & Regulatory Bodies, Industrial & Manufacturing, Others. By Geography: North America, South America, Europe, Middle East and Africa, Asia-Pacific. Key Attributes Report Attribute Details No. of Pages 150 Forecast Period 2025-2030 Estimated Market Value (USD) in 2025 $19.51 Billion Forecasted Market Value (USD) by 2030 $27.31 Billion Compound Annual Growth Rate 6.9% Regions Covered Global Key Topics Covered1. EXECUTIVE SUMMARY2. MARKET SNAPSHOT2.1. Market Overview2.2. Market Definition2.3. Scope of the Study2.4. Market Segmentation3. BUSINESS LANDSCAPE3.1. Market Drivers3.2. Market Restraints3.3. Market Opportunities3.4. Porter's Five Forces Analysis3.5. Industry Value Chain Analysis3.6. Policies and Regulations3.7. Strategic Recommendations4. TECHNOLOGICAL OUTLOOK5. GLOBAL LAB EQUIPMENT MARKET BY TYPE5.1. Introduction5.2. Analytical Instruments5.3. General Lab Equipment5.4. Measuring & Monitoring Devices5.5. Specialty Equipment5.6. Support Equipment6. GLOBAL LAB EQUIPMENT MARKET BY END-USER6.1. Introduction6.2. Academic & Research Institutes6.3. Biopharmaceutical & Pharmaceutical Companies6.4. Healthcare & Diagnostic Labs6.5. Government & Regulatory Bodies6.6. Industrial & Manufacturing6.7. Others7. GLOBAL LAB EQUIPMENT MARKET BY GEOGRAPHY7.1. Introduction7.2. North America7.3. South America7.4. Europe7.5. Middle East and Africa7.6. Asia-Pacific8. COMPETITIVE ENVIRONMENT AND ANALYSIS8.1. Major Players and Strategy Analysis8.2. Market Share Analysis8.3. Mergers, Acquisitions, Agreements, and Collaborations8.4. Competitive Dashboard9. COMPANY PROFILES9.1. Eppendorf AG9.2. Beckman Coulter, Inc.9.3. Agilent Technologies, Inc.9.4. Thermo Fisher Scientific Inc.9.5. Waters Corporation9.6. F. Hoffmann-La Roche Ltd9.7. Shimadzu Corporation9.8. Bio-Rad Laboratories, Inc.9.9. PerkinElmer Inc.10. APPENDIX For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Lab Equipment Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
